Skip to content
10-Q

Quarterly Report

Omega Therapeutics, Inc.

0000950170-24-091197

← back to feed
Filed
Aug 6, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 1, 2024 55.15M sh
Shares Diluted Q2 2024 · Jun 30, 2024 55.15M sh
Shares Diluted Q2 2024 · Jun 30, 2024 55.15M sh
Shares Diluted Q2 2024 · Jun 30, 2023 55.07M sh
Shares Diluted Q2 2024 · Jun 30, 2023 52.86M sh
Capex Q2 2024 · Jun 30, 2024 $931K
Capex Q2 2024 · Jun 30, 2023 $1.03M
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$24.48M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$51.38M
Long Term Debt Q2 2024 · Jun 30, 2024 $12.91M
Long Term Debt Q2 2024 · Dec 31, 2023 $14.89M
Short Term Debt Q2 2024 · Jun 30, 2024 $4M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $45.85M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $68.44M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $105.54M
Stockholders Equity Q2 2024 · Jun 30, 2024 $26.26M
Stockholders Equity Q2 2024 · Mar 31, 2024 $41.35M
Stockholders Equity Q2 2024 · Dec 31, 2023 $58.02M
Stockholders Equity Q2 2024 · Jun 30, 2023 $95.92M
Stockholders Equity Q2 2024 · Mar 31, 2023 $123M
Stockholders Equity Q2 2024 · Dec 31, 2022 $105.97M
Current Liabilities Q2 2024 · Jun 30, 2024 $25.54M
Current Liabilities Q2 2024 · Dec 31, 2023 $26.81M
Total Liabilities Q2 2024 · Jun 30, 2024 $141.96M
Total Liabilities Q2 2024 · Dec 31, 2023 $146.35M
Current Assets Q2 2024 · Jun 30, 2024 $56.06M
Current Assets Q2 2024 · Dec 31, 2023 $89.88M
Total Assets Q2 2024 · Jun 30, 2024 $168.23M
Total Assets Q2 2024 · Dec 31, 2023 $204.37M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.30
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.66
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.54
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.04
Eps Basic Q2 2024 · Jun 30, 2024 −$0.30
Eps Basic Q2 2024 · Jun 30, 2024 −$0.66
Eps Basic Q2 2024 · Jun 30, 2023 −$0.54
Eps Basic Q2 2024 · Jun 30, 2023 −$1.04
Sga Expense Q2 2024 · Jun 30, 2024 $5.77M
Sga Expense Q2 2024 · Jun 30, 2024 $13.17M
Sga Expense restated Q2 2024 · Jun 30, 2023 $6.56M
Sga Expense restated Q2 2024 · Jun 30, 2023 $12.8M
Rd Expense Q2 2024 · Jun 30, 2024 $12.94M
Rd Expense Q2 2024 · Jun 30, 2024 $28.36M
Rd Expense restated Q2 2024 · Jun 30, 2023 $25.04M
Rd Expense restated Q2 2024 · Jun 30, 2023 $45.13M
Net Income Q2 2024 · Jun 30, 2024 −$16.31M
Net Income Q2 2024 · Jun 30, 2024 −$36.43M
Net Income Q2 2024 · Mar 31, 2024 −$20.13M
Net Income Q2 2024 · Jun 30, 2023 −$29.69M
Net Income Q2 2024 · Jun 30, 2023 −$54.97M
Net Income Q2 2024 · Mar 31, 2023 −$25.28M
Operating Income Q2 2024 · Jun 30, 2024 −$16.58M
Operating Income Q2 2024 · Jun 30, 2024 −$37.03M
Operating Income Q2 2024 · Jun 30, 2023 −$30.84M
Operating Income Q2 2024 · Jun 30, 2023 −$56.66M